Search Results - "KANESHIGE, Kimberly"

Impact of “Nuisance” Bleeding on Clopidogrel Compliance in Patients Undergoing Intracoronary Drug-Eluting Stent Implantation by Roy, Probal, MD, Bonello, Laurent, MD, Torguson, Rebecca, MPH, de Labriolle, Axel, MD, Lemesle, Gilles, MD, Slottow, Tina L. Pinto, MD, Steinberg, Daniel H., MD, Kaneshige, Kimberly, BS, Xue, Zhenyi, MS, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Suddath, William O., MD, Pichard, Augusto D., MD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Premature cessation of clopidogrel is a strong risk factor for drug-eluting stent thrombosis in patients undergoing percutaneous coronary intervention. The…”
Get full text

Comparison of Safety, Efficacy, and Outcome of Successful Versus Unsuccessful Percutaneous Coronary Intervention in “True” Chronic Total Occlusions by de Labriolle, Axel, MD, Bonello, Laurent, MD, Roy, Probal, MBBS, Lemesle, Gilles, MD, Steinberg, Daniel H., MD, Xue, Zhenyi, MS, Kaneshige, Kimberly, BS, Suddath, William O., MD, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Pichard, Augusto D., MD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Despite improving techniques for opening chronic total occlusions (CTOs), the benefit of successful recanalization of the artery remains unclear. The aims of…”
Get full text

Does Black Ethnicity Influence the Development of Stent Thrombosis in the Drug-Eluting Stent Era? by COLLINS, Sara D, TORGUSON, Rebecca, KENT, Kenneth M, PICHARD, Augusto D, SUDDATH, William O, SATLER, Lowell F, WAKSMAN, Ron, GAGLIA, Michael A, LEMESLE, Gilles, SYED, Asmir I, BEN-DOR, Itsik, YANLIN LI, MALUENDA, Gabriel, KANESHIGE, Kimberly, ZHENYI XUE

“…It has been suggested that black race predicts stent thrombosis (ST) after drug-eluting stent implantation. Whether socioeconomic status or comorbid conditions…”
Get full text

Observations and Outcomes of Definite and Probable Drug-Eluting Stent Thrombosis Seen at a Single Hospital in a Four-Year Period by Pinto Slottow, Tina L., MD, Steinberg, Daniel H., MD, Roy, Probal K., MD, Buch, Ashesh N., MD, Okabe, Teruo, MD, Xue, Zhenyi, MS, Kaneshige, Kimberly, BS, Torguson, Rebecca, MS, Lindsay, Joseph, MD, Pichard, Augusto D., MD, Satler, Lowell F., MD, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Waksman, Ron, MD

“…Stent thrombosis (ST) is a major safety concern after drug-eluting stent (DES) deployment, resulting in significant morbidity and mortality. The goal of this…”
Get full text

Requirement for Emergent Coronary Artery Bypass Surgery Following Percutaneous Coronary Intervention in the Stent Era by Roy, Probal, MD, de Labriolle, Axel, MD, Hanna, Nicholas, MD, Bonello, Laurent, MD, Okabe, Teruo, MD, Pinto Slottow, Tina L., MD, Steinberg, Daniel H., MD, Torguson, Rebecca, MPH, Kaneshige, Kimberly, BS, Xue, Zhenyi, MS, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Suddath, William O., MD, Pichard, Augusto D., MD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Performance of percutaneous coronary intervention (PCI) at centers without cardiothoracic surgery is a contentious issue. Although this practice allows greater…”
Get full text

Long-Term Prognostic Value of Preprocedural C-Reactive Protein After Drug-Eluting Stent Implantation by Delhaye, Cedric, MD, Maluenda, Gabriel, MD, Wakabayashi, Kohei, MD, Ben-Dor, Itsik, MD, Lemesle, Gilles, MD, Collins, Sara D., MD, Syed, Asmir I., MD, Torguson, Rebecca, MPH, Kaneshige, Kimberly, BS, Xue, Zhenyi, MS, Suddath, William O., MD, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…C-reactive protein (CRP) elevation is associated with an adverse cardiovascular prognosis after bare metal stent implantation. Data have suggested a similar…”
Get full text

Correlates and Outcomes of Late and Very Late Drug-Eluting Stent Thrombosis by Waksman, Ron, MD, Kirtane, Ajay J., MD, Torguson, Rebecca, MD, Cohen, David J., MD, Ryan, Thomas, MD, Räber, Lorenz, MD, Applegate, Robert, MD, Waxman, Sergio, MD, Gordon, Paul, MD, Kaneshige, Kimberly, BS, Leon, Martin B., MD

“…Abstract Objectives The aim of this study was to identify clinical, procedural, and angiographic correlates of late/very late drug-eluting stent (DES)…”
Get full text

Prognostic Value of Hemoglobin A1C Levels in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention With Stent Implantation by Lemesle, Gilles, MD, Bonello, Laurent, MD, de Labriolle, Axel, MD, Maluenda, Gabriel, MD, Syed, Asmir I., MD, Collins, Sara D., MD, Ben-Dor, Itsik, MD, Torguson, Rebecca, MPH, Kaneshige, Kimberly, BS, Xue, Zhenyi, MS, Suddath, William O., MD, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…The optimal glycosylated hemoglobin (HbA1C) target in diabetic patients is a subject of ongoing controversy that may be especially pertinent in diabetic…”
Get full text

Temporal Relation Between Clopidogrel Cessation and Stent Thrombosis After Drug-Eluting Stent Implantation by Roy, Probal, MD, Bonello, Laurent, MD, Torguson, Rebecca, MPH, Okabe, Teruo, MD, Pinto Slottow, Tina L., MD, Steinberg, Daniel H., MD, Kaneshige, Kimberly, BS, Xue, Zhenyi, MS, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Suddath, William O., MD, Pichard, Augusto D., MD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…The risk of late thrombotic events and the need for prolonged dual antiplatelet therapy detract from the clinical advantage offered by drug-eluting stents…”
Get full text

Incidence, correlates, and clinical impact of nuisance bleeding after antiplatelet therapy for patients with drug-eluting stents by Ben-Dor, Itsik, MD, Torguson, Rebecca, MPH, Scheinowitz, Mickey, PhD, Li, Yanlin, MD, Delhaye, Cedric, MD, Wakabayashi, Kohei, MD, Maluenda, Gabriel, MD, Syed, Asmir I., MD, Collins, Sara D., MD, Gonzalez, Manuel A., MD, MPH, Gaglia, Michael A., MD, MSc, Xue, Zhenyi, MS, Kaneshige, Kimberly, BS, Satler, Lowell F., MD, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Background Nuisance bleeding (NB) after dual antiplatelet therapy (DAPT) is not well characterized despite its potential to impact patient compliance. We…”
Get full text

Prognostic value of the syntax score in patients undergoing coronary artery bypass grafting for three-vessel coronary artery disease by Lemesle, Gilles, Bonello, Laurent, de Labriolle, Axel, Steinberg, Daniel H., Roy, Probal, Slottow, Tina L. Pinto, Torguson, Rebecca, Kaneshige, Kimberly, Xue, Zhenyi, Suddath, William O., Satler, Lowell F., Kent, Kenneth M., Lindsay, Joseph, Pichard, Augusto D., Waksman, Ron

“…Background: The Syntax score prognostic value has recently been highlighted in patients undergoing percutaneous coronary intervention (PCI) for multivessel…”
Get full text

Prevalence of Aspirin and Clopidogrel Resistance Among Patients With and Without Drug-Eluting Stent Thrombosis by Pinto Slottow, Tina L., MD, Bonello, Laurent, MD, Gavini, Rekha, BS, Beauzile, Patricia, BS, Sushinsky, Steven J., BS, Scheinowitz, Mickey, PhD, Kaneshige, Kimberly, BS, Xue, Zhenyi, MS, Torguson, Rebecca, MPH, Tantry, Udaya, PhD, Pichard, Augusto D., MD, Satler, Lowell F., MD, Suddath, William O., MD, Kent, Kenneth, MD, PhD, Gurbel, Paul, MD, Waksman, Ron, MD

“…Drug-eluting stent (DES) thrombosis has a multifactorial etiology. Variable responsiveness to antiplatelet therapy likely contributes to its pathogenesis. We…”
Get full text

Effect of Insurance Type on Adverse Cardiac Events After Percutaneous Coronary Intervention by Gaglia, Michael A., MD, MSc, Torguson, Rebecca, MPH, Xue, Zhenyi, MS, Gonzalez, Manuel A., MD, MPH, Ben-Dor, Itsik, MD, Maluenda, Gabriel, MD, Mahmoudi, Michael, MD, Sardi, Gabriel, MD, Wakabayashi, Kohei, MD, Kaneshige, Kimberly, BS, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Previous studies have documented disparities in both access to invasive cardiovascular procedures and outcomes in patients with Medicaid, Medicare, or no…”
Get full text

Percutaneous Coronary Intervention With Second-Generation Paclitaxel -Eluting Stents Versus Everolimus -Eluting Stents in United States Contemporary Practice (REWARDS TLX Trial) by Waksman, Ron, MD, Ghali, Magdi, MD, Goodroe, Randy, MD, Ryan, Thomas, MD, Turco, Mark, MD, Ring, Michael, MD, McGarry, Thomas, MD, Dobies, David, MD, Shammas, Nicolas, MD, Steinberg, Daniel H., MD, Swymelar, Stacy, BS, Kaneshige, Kimberly, BS, Torguson, Rebecca, MPH

“…Registry Experience at the Washington Hospital Center, DES - Taxus Liberte Versus Xience V (REWARDS TLX) is a physician-initiated, retrospective, real-world,…”
Get full text

Insurance Type Influences the Use of Drug-Eluting Stents by Gaglia, Michael A., MD, MSc, Torguson, Rebecca, MPH, Xue, Zhenyi, MS, Gonzalez, Manuel A., MD, MPH, Collins, Sara D., MD, Ben-Dor, Itsik, MD, Syed, Asmir I., MD, Maluenda, Gabriel, MD, Delhaye, Cedric, MD, Hanna, Nicholas, MD, Wakabayashi, Kohei, MD, Kaneshige, Kimberly, BS, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Objectives We sought to examine the effect of insurance type upon the likelihood of receiving a drug-eluting stent (DES). Background Recent guidelines suggest…”
Get full text

Racial Disparities in Outcomes Following Percutaneous Coronary Intervention With Drug-Eluting Stents by Gaglia, Michael A., MD, MSc, Steinberg, Daniel H., MD, Pinto Slottow, Tina L., MD, Roy, Probal K., MD, Bonello, Laurent, MD, DeLabriolle, Axel, MD, Lemesle, Gilles, MD, Okabe, Teruo, MD, Torguson, Rebecca, MPH, Kaneshige, Kimberly, BS, Xue, Zhenyi, MS, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Lindsay, Joseph, MD, Waksman, Ron, MD

“…Previous research has documented that African-Americans compared with non–African-Americans have higher rates of adverse cardiac outcomes and are less likely…”
Get full text

The clinical significance of hematocrit values before and after percutaneous coronary intervention by Maluenda, Gabriel, MD, Lemesle, Gilles, MD, Collins, Sara D., MD, Ben-Dor, Itsik, MD, Syed, Asmir I., MD, Torguson, Rebecca, MPH, Kaneshige, Kimberly, BS, Xue, Zhenyi, MS, Pakala, Rajbabu, PhD, Suddath, William O., MD, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Background The presence of anemia before percutaneous coronary intervention (PCI) and/or the development of bleeding or anemia after PCI has been shown to…”
Get full text

Correlates and Consequences of Gastrointestinal Bleeding Complicating Percutaneous Coronary Intervention by Gaglia, Michael A., MD, MSc, Torguson, Rebecca, MPH, Gonzalez, Manuel A., MD, MPH, Ben-Dor, Itsik, MD, Maluenda, Gabriel, MD, Collins, Sara D., MD, Syed, Asmir I., MD, Delhaye, Cedric, MD, Wakabayashi, Kohei, MD, Belle, Loic, MD, Mahmoudi, Michael, MD, Hanna, Nicholas, MD, Xue, Zhenyi, MS, Kaneshige, Kimberly, BS, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Satler, Lowell F., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Gastrointestinal bleeding (GIB) complicating percutaneous coronary intervention (PCI) results in high mortality, but clinical factors associated with and…”
Get full text

Three-Year Outcomes Following Sirolimus - Versus Paclitaxel -Eluting Stent Implantation in an Unselected Population With Coronary Artery Disease (from the REWARDS Registry) by Hanna, Nicholas N., MD, Gaglia, Michael A., MD, MSc, Torguson, Rebecca, MPH, Ben-Dor, Itsik, MD, Gonzalez, Manuel A., MD, MPH, Collins, Sara D., MD, Syed, Asmir I., MD, Maluenda, Gabriel, MD, Kaneshige, Kimberly, BS, Xue, Zhenyi, MS, Satler, Lowell F., MD, Kent, Kenneth M., MD, PhD, Suddath, William O., MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…The Registry Experience at the Washington Hospital Center with Drug-Eluting Stents (REWARDS) study includes unselected patients with coronary artery disease…”
Get full text

Effect of Drug-Eluting Stents on Frequency of Repeat Revascularization in Patients With Unstable Angina Pectoris or Non-ST-Elevation Myocardial Infarction by Li, Yanlin, MD, Torguson, Rebecca, MPH, Syed, Asmir I., MD, Ben-Dor, Itsik, MD, Collins, Sara D., MD, Maluenda, Gabriel, MD, Scheinowitz, Mickey, PhD, Kaneshige, Kimberly, BS, Xue, Zhenyi, MS, Lemesle, Gilles, MD, Satler, Lowell F., MD, Suddath, William O., MD, Kent, Kenneth M., MD, PhD, Lindsay, Joseph, MD, Pichard, Augusto D., MD, Waksman, Ron, MD

“…Drug-eluting stents (DES) have been shown to markedly reduce the need for repeat revascularization compared to bare-metal stents in patients with stable…”
Get full text